Selected article for: "acute severe and adequate treatment"

Author: Sánchez, Juan Bautista; Cuipal Alcalde, Juan Diego; Ramos Isidro, Rossi; Luna, Carlos Zúñiga; Cubas, W Samir; Coaguila Charres, André; Gutiérrez, José Egoávil; Ochoa, Juan David; Arias, Patricia Fernández
Title: Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19
  • Cord-id: vl5v67wx
  • Document date: 2020_12_31
  • ID: vl5v67wx
    Snippet: BACKGROUND: Coronavirus disease 2019 (COVID-19) infection can cause alterations in the coagulation mechanism conditioning thrombotic phenomena such as acute limb ischemia (ALI) as the only manifestation of the infection. The aim of the study was to describe clinical and surgical characteristics of a group of patients infected with severe acute respiratory syndrome coronavirus 2 who presented ALI in the context of the COVID-19 pandemic at Lima, Peru. METHODS: A multicenter, observational, and ret
    Document: BACKGROUND: Coronavirus disease 2019 (COVID-19) infection can cause alterations in the coagulation mechanism conditioning thrombotic phenomena such as acute limb ischemia (ALI) as the only manifestation of the infection. The aim of the study was to describe clinical and surgical characteristics of a group of patients infected with severe acute respiratory syndrome coronavirus 2 who presented ALI in the context of the COVID-19 pandemic at Lima, Peru. METHODS: A multicenter, observational, and retrospective study was performed in six general hospitals, from March to July 2020. The variables considered were the pathological history and associated habits, laboratory tests, the severity of COVID-19 infection and ALI, the anatomic location of the lesion, treatment, evolution, and discharge conditions. RESULTS: Thirty patients with ALI infected with COVID-19 were evaluated. Their mean age was 60 ± 15 years, the condition being more frequent in men (76.6%). The main comorbidities were arterial hypertension (33.3%), obesity (33.3%), and diabetes mellitus 2 (26.6%). There were 23.3% asymptomatic patients, and their only manifestation was ALI. Rutherford IIA and IIB stage included 93.2% of patients. The most frequent location of the thrombosis was the lower limbs (73.3% vs. 26.6%). Thrombectomy was performed in 76.6% of the patients, and amputation (primary and secondary) was performed in 30% of the patients. The mortality rate was 23.3%, all of it because of acute respiratory distress syndrome. CONCLUSIONS: ALI is a vascular pathology associated with embolic and thrombotic processes. COVID-19 infection can cause severe alterations in coagulation mechanisms, leading some patients to present severe acute arterial complications such as thrombosis, as the only associated manifestation. We report a younger cohort than those described in other studies and with a high frequency of amputations despite adequate surgical treatment.

    Search related documents:
    Co phrase search for related documents
    • activity condition and acute respiratory distress syndrome: 1, 2
    • activity condition and low molecular weight: 1
    • acute arterial thrombosis and low molecular weight: 1, 2, 3
    • acute limb and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8
    • acute limb ischemia and low molecular weight: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • lmwh anticoagulation therapy and low molecular weight: 1, 2, 3